Researchers got the immune-boosting results they wanted from Moderna's vaccine candidate
The results from the first phase of Moderna's coronavirus vaccine trial are out, and the promising findings are in line with some early data from the study released in May.
The study, published Tuesday in The New England Journal of Medicine, found the experimental mRNA vaccine — which requires two doses a month apart — induced coronavirus immune responses in all 45 participants, just as scientists had hoped. There were some mild side effects, including fatigue, chills, and fevers, but The Associated Press notes those aren't uncommon with other vaccines, and there have been no major safety concerns.
Moderna will begin its final step at the end of July, a 30,000-person study to prove if the shots are strong enough to protect people from the virus. While the first phase does indicate the vaccine produces antibodies geared toward fighting off the virus, it's less clear if the levels of antibodies are enough to actually fend off infection. Read the full results of the study at The New England Journal of Medicine, as well as more context at The Associated Press.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
6 scenic white water rafting destinations to get your heart racing
The Week Recommends Have a rip-roaring time on the water
By Catherine Garcia, The Week US Published
-
Dangerous substances in Lunchables are raising concerns over children's health
In the Spotlight High levels of lead and sodium were recently found in the snack packages
By Justin Klawans, The Week US Published
-
The Week contest: Fired art
Puzzles and Quizzes
By The Week US Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published
-
Seattle Children's Hospital sues Texas over 'sham' demand for transgender medical records
Speed Read Texas Attorney General Ken Paxton subpoenaed records of any Texan who received gender-affirming care at the Washington hospital
By Peter Weber, The Week US Published
-
Afghanistan has a growing female suicide problem
Speed Read The Taliban has steadily whittled away women's and girls' rights in Afghanistan over the past 2 years, prompting a surge in depression and suicide
By Peter Weber, The Week US Published
-
US life expectancy rose in 2022 but not to pre-pandemic levels
Speed Read Life expectancy is slowly crawling back up
By Devika Rao, The Week US Published
-
Vallance diaries: Boris Johnson 'bamboozled' by Covid science
Speed Read Then PM struggled to get his head around key terms and stats, chief scientific advisor claims
By The Week UK Published
-
An increasing number of dog owners are 'vaccine hesitant' about rabies
Speed Read A new survey points to canine vaccine hesitancy
By Devika Rao, The Week US Published